Towards patient-based cancer therapeutics (Q34125699)

31 July 2017

title

Towards patient-based cancer therapeutics (English)

1 reference

31 July 2017

1 reference

27

Lynda Chin

1 reference

31 July 2017

17

Lincoln Stein

1 reference

31 July 2017

23

Laura Pasqualucci

1 reference

31 July 2017

19

Andrea Califano

1 reference

31 July 2017

26

William C Hahn

1 reference

31 July 2017

32

David E Root

1 reference

31 July 2017

29

Jesse S Boehm

1 reference

31 July 2017

33

Barbara A Weir

1 reference

31 July 2017

28

Ronald A DePinho

1 reference

31 July 2017

2

Stuart L Schreiber

1 reference

31 July 2017

author name string

Cancer Target Discovery and Development Network

1

1 reference

31 July 2017

Alykhan F Shamji

3

1 reference

31 July 2017

Paul A Clemons

4

1 reference

31 July 2017

Cindy Hon

5

1 reference

31 July 2017

Angela N Koehler

6

1 reference

31 July 2017

Benito Munoz

7

1 reference

31 July 2017

Michelle Palmer

8

1 reference

31 July 2017

Andrew M Stern

9

1 reference

31 July 2017

Bridget K Wagner

10

1 reference

31 July 2017

Scott Powers

11

1 reference

31 July 2017

Scott W Lowe

12

1 reference

31 July 2017

Xuecui Guo

13

1 reference

31 July 2017

Alex Krasnitz

14

1 reference

31 July 2017

Eric T Sawey

15

1 reference

31 July 2017

Raffaella Sordella

16

1 reference

31 July 2017

Lloyd C Trotman

18

1 reference

31 July 2017

Riccardo Dalla-Favera

20

1 reference

31 July 2017

Adolfo Ferrando

21

1 reference

31 July 2017

Antonio Iavarone

22

1 reference

31 July 2017

José Silva

24

1 reference

31 July 2017

Brent R Stockwell

25

1 reference

31 July 2017

Shuba Gopal

30

1 reference

31 July 2017

Alan Huang

31

1 reference

31 July 2017

Daniela S Gerhard

34

1 reference

31 July 2017

Jean Claude Zenklusen

35

1 reference

31 July 2017

Michael G Roth

36

1 reference

31 July 2017

Michael A White

37

1 reference

31 July 2017

John D Minna

38

1 reference

31 July 2017

John B MacMillan

39

1 reference

31 July 2017

Bruce A Posner

40

1 reference

31 July 2017

publication date

1 September 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

904-906

1 reference

Probing the probes: fitness factors for small molecule tools

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

The transcriptional network for mesenchymal transformation of brain tumours.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Mouse models of human AML accurately predict chemotherapy response

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Principles of cancer therapy: oncogene and non-oncogene addiction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Synthetic lethal screen identification of chemosensitizer loci in cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

The art of the chemical probe

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Attacking cancer at its root

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Modeling genomic diversity and tumor dependency in malignant melanoma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939009

Limits on Medicare's ability to control rising spending on cancer drugs

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20829823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeted cancer therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20829823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20829823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NBT0910-904

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference